C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/18 (2006.01) A61K 39/29 (2006.01) A61P 31/14 (2006.01) C07K 16/10 (2006.01) C12N 15/51 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2387666
The present invention relates to HCV proteins in which cysteine residues are reversibly protected during purification. Eventually, this purification procedure results in HCV proteins with biological activity and a native-like protein conformation, which present corresponding epitopes. The present invention pertains also to drug screening methods using these HCV proteins, and diagnostic and therapeutic applications, such as vaccines and drugs.
La présente invention concerne des protéines HCV dans lesquelles les résidus de cystéine sont protégés de façon réversible durant la purification. Cette procédure de purification donne finalement des protéines HCV qui présentent une activité biologique, une conformation protéinique de type endogène et des épitopes correspondants. Cette invention concerne aussi des techniques de recherche de médicament utilisant ces protéines HCV, et des applications diagnostiques et thérapeutiques, telles que des vaccins et des médicaments.
Bosman Alfons
Depla Erik
Maertens Geert
Innogenetics N.v.
Smart & Biggar
LandOfFree
Redox reversible hcv proteins with native-like conformation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Redox reversible hcv proteins with native-like conformation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Redox reversible hcv proteins with native-like conformation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1723493